A6527012
Orotic Acid Monohydrate , 98% , 50887-69-9
Synonym(s):
2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid
CAS NO.:50887-69-9
Empirical Formula: C5H6N2O5
Molecular Weight: 174.11
MDL number: MFCD00149398
EINECS: 610-580-2
Pack Size | Price | Stock | Quantity |
25G | RMB51.20 | In Stock |
|
100G | RMB94.40 | In Stock |
|
500G | RMB372.80 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | >300 °C(lit.) |
storage temp. | Sealed in dry,Room Temperature |
solubility | Aqueous Base (Slightly), DMSO (Slightly) |
form | Crystalline Powder |
color | White to off-white |
Water Solubility | Soluble in water (1.7 mg/ml), and ammonium hydroxide. Insoluble in chloroform. |
Merck | 14,6876 |
BRN | 383901 |
InChI | InChI=1S/C5H4N2O4.H2O/c8-3-1-2(4(9)10)6-5(11)7-3;/h1H,(H,9,10)(H2,6,7,8,11);1H2 |
InChIKey | YXUZGLGRBBHYFZ-UHFFFAOYSA-N |
SMILES | C1(C(=O)O)NC(NC(=O)C=1)=O.O |
CAS DataBase Reference | 50887-69-9(CAS DataBase Reference) |
Description and Uses
Orotic Acid is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 3 |
RTECS | RM3180000 |
TSCA | Yes |
HS Code | 29335990 |